Skip to main content

Want a detailed portfolio tracker?

GH Research (GHRS) P/E (2021 - 2026)

GH Research (GHRS) P/E from Jun 25, 2021 to Jul 20, 2026. The TTM GH Research (GHRS) P/E is -30.27. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of GH Research (GHRS)

YearP/EChange
2026-30.27+88.29%
2025-16.08+71.96%
2024-9.35+26.75%
2023-7.38-85.47%
2022-50.77-58.57%
2021-122.53N/A

Comparison GH Research (GHRS) P/E with competitors

GH Research (GHRS) P/E is -30.27.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.25%
FGENFibroGen Inc0.24-100.79%
CHRSCoherus Biosciences Inc0.85-102.80%
FBIOFortress Biotech Inc0.95-103.14%
ORMPOramed Pharmaceuticals Inc1.50-104.97%
AGENAgenus Inc3.01-109.94%
INVAInnoviva Inc3.15-110.42%
VXRTVaxart Inc3.55-111.73%
CRMDCorMedix Inc3.63-111.99%
CVACCureVac N.V.4.45-114.69%
GLPGGalapagos NV4.86-116.05%
SRPTSarepta Therapeutics Inc4.88-116.13%
ABEOAbeona Therapeutics Inc5.39-117.80%
ABUSArbutus Biopharma Corp5.60-118.49%
ZVRAZevra Therapeutics Inc5.89-119.45%
SPROSpero Therapeutics Inc6.23-120.58%
CGENCompugen Ltd6.31-120.86%
RIGLRigel Pharmaceuticals6.87-122.70%
SLXNSilexion Therapeutics Corp7.30-124.10%
OMEROmeros Corporation9.26-130.59%
AUPHAurinia Pharmaceuticals Inc9.58-131.67%
PLXProtalix BioTherapeutics Inc10.89-135.98%
ACADAcadia Pharmaceuticals Inc11.73-138.75%
TBPHTheravance Biopharma Inc12.26-140.51%
ADMAAdma Biologics Inc12.42-141.03%
HRMYHarmony Biosciences Holdings Inc13.82-145.66%
SABSSAB Biotherapeutics Inc14.14-146.70%
NAGENiagen Bioscience Inc14.82-148.95%
INCYIncyte Corp15.82-152.27%
REGNRegeneron Pharmaceuticals Inc15.86-152.39%
PBYIPuma Biotechnology Inc17.32-157.21%
CPRXCatalyst Pharmaceuticals Inc17.44-157.61%
EXELExelixis Inc17.54-157.94%
TGTXTG Therapeutics Inc18.97-162.66%
MDXGMimedx Group Inc20.55-167.90%
XOMAXOMA Royalty Corp22.87-175.57%
ARGXArgen X SE24.30-180.28%
CTMXCytomX Therapeutics Inc24.82-182.00%
XOMAOXOMA Royalty Corp25.34-183.73%
HALOHalozyme Therapeutics Inc25.62-184.66%
XOMAPXOMA Royalty Corp25.67-184.81%
VRTXVertex Pharmaceuticals Inc27.99-192.49%
RPRXRoyalty Pharma plc - Class A28.69-194.78%
SLNOSoleno Therapeutics Inc29.02-195.86%
ASNDAscendis Pharma A/S30.09-199.40%
LGNDLigand Pharmaceuticals Inc - Class B37.91-225.25%
APLSApellis Pharmaceuticals Inc39.02-228.92%
BMRNBiomarin Pharmaceutical Inc42.21-239.46%
KRYSKrystal Biotech Inc45.34-249.81%
ONCBeiGene Ltd69.54-329.75%
PHARPharming Group N.V.75.03-347.87%
TECHBio-Techne Corp101.96-436.85%
VCELVericel Corp109.92-463.16%
ALNYAlnylam Pharmaceuticals Inc117.96-489.73%
GMABGenmab140.29-563.49%
TLXTelix Pharmaceuticals Ltd162.15-635.72%
CORTCorcept Therapeutics Inc212.86-803.24%